The Mouse Monoclonal anti-RSV Fusion Protein antibody has been validated for ELISA, IF, WB, FACS, IEM and IP. It is suitable to detect RSV Fusion Protein in samples from Respiratory Syncytial Virus (RSV). There are 3+ publications available.
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Format
Liquid
Concentration
1.0 mg/mL
Adams, Bonzel, Kovacevic, Mayatepek, Hoehn, Vogel: "Palivizumab-resistant human respiratory syncytial virus infection in infancy." in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 51, Issue 2, pp. 185-8, (2010) (PubMed).
Eckardt-Michel, Lorek, Baxmann, Grunwald, Keil, Zimmer: "The fusion protein of respiratory syncytial virus triggers p53-dependent apoptosis." in: Journal of virology, Vol. 82, Issue 7, pp. 3236-49, (2008) (PubMed).
Mason, Lawetz, Gaudette, Dô, Scouten, Lagacé, Simoneau, Liuzzi: "Polyadenylation-dependent screening assay for respiratory syncytial virus RNA transcriptase activity and identification of an inhibitor." in: Nucleic acids research, Vol. 32, Issue 16, pp. 4758-67, (2004) (PubMed).
Target
RSV Fusion Protein (RSV F)
(Respiratory Syncytial Virus Fusion Protein (RSV F))